British Society for Rheumatology (BSR)
The ACR recently finalized a two-year licensing agreement with the BSR that makes the BSR the ACR’s partner in distributing its Simple Tasks campaign in the United Kingdom.
Over the next two years, the ACR will assist the BSR in implementing the campaign to increase the value of rheumatology among key influencers in the United Kingdom. More specifically, the U.K.version of the campaign will aim to increase commissioners’ understanding of the complexities involved in supporting people with rheumatic conditions, increase commissioner support of multidisciplinary rheumatology teams, and foster earlier diagnosis and treatment for people with rheumatic conditions.
Also, ARHP President Dr. Richardson joined the BSR for its annual meeting in April, where she witnessed the fruition of 12 months of collaborative work between the ARHP and the BSR’s British Health Professionals in Rheumatology (BHPR). Similar to the ACR/ARHP, the BSR/BHPR determined that, since people with rheumatic diseases should be treated by a team of rheumatology professionals, there should be one society representing them. To assist BRS/BHRP in their restructuring and merger into one organization, ARHP leadership and staff served as consultants to the BSR/BHPR.
The scope and importance of ACR and ARHP international collaboration is impressive and growing every day. The tangible benefit will be to our members and the global rheumatology community as we advance rheumatology around the world. Based on our record of success, we would predict that the future is bright for continued productive collaborations!
Dr. Uknis is professor of medicine and senior associate dean for admissions and strategy at Temple University in Philadelphia. Contact her at [email protected].
Dr. Richardson is chief clinical officer for Universal SmartComp of Washington, PA, and professor emeritus with Duke University Medical Center School of Medicine in Durham, N.C. Contact her at [email protected].
ILAR Call for Proposals
Help advance rheumatology in developing countries. ILAR is issuing its yearly request for proposals for projects that advance rheumatology in developing countries.
ILAR is soliciting proposals for projects for the funding year January 1–December 31, 2014. ILAR welcomes project proposals for grants between the amounts of $5,000 and $30,000 U.S. In total, ILAR will fund at least $125,000 of projects in 2014. ILAR’s intent in funding these projects is to provide seed money to help initiate meritorious projects that will eventually be eligible for other sources of funding.
